What is it?

Mucopolysaccharidosis type VII (MPS VII) is a rare genetic metabolic disorder.

What causes it?

People with MPS VII do not produce enough beta-glucuronidase, an enzyme that plays a key part in the breakdown off specific sugars in the body. The lack of beta-glucuronidase leads to storage of sugars within the cells, leading to progressive damage in many organs.

What are some of the common symptoms?

  • Cataracts
  • Clouding of the corneas
  • Developmental delay
  • Enlarged spleen and liver
  • Joint stiffness
  • Hearing loss
  • Heart and lung complications
  • Short stature

How many people have it?

It is estimated that fewer than 1 in 1,000,000 people have MPS VII.1

Common names for MPS VII

  • Sly Syndrome
  • MPS 7
The Significant 7: Important facts about MPS VII

If you or someone you care for is living with MPS VII, keep these seven facts in mind as you navigate your journey.

Ultragenyx Opportunities to Participate

Research plays a critical part in advancing science and treatments. Volunteers who participate in this research are essential. Future therapies would not be possible without them. Participating in clinical trials, interviews, observational studies, and disease monitoring programs help to drive research, treatment development, and disease education. It is also a way to advocate for yourself and your community. To learn more about Ultragenyx research, email [email protected].

*These organizations are an incomplete listing of rare disease support organizations and are not controlled by, endorsed by, or affiliated with Ultragenyx Pharmaceutical Inc. The list is meant for informational purposes only and is not intended to replace your healthcare professional’s medical advice. Ask your doctor or nurse any questions you may have about your disease or treatment plan. If you would like to have your group added to the list, please contact [email protected].